Beyond mild, moderate, and severe traumatic brain injury: modelling severity from clinical, neuroimaging, and blood-based indicators
- PMID: 41192220
- PMCID: PMC12637077
- DOI: 10.1016/j.ebiom.2025.106001
Beyond mild, moderate, and severe traumatic brain injury: modelling severity from clinical, neuroimaging, and blood-based indicators
Abstract
Background: The conventional clinical approach to characterising traumatic brain injuries (TBIs) as mild, moderate, or severe using the Glasgow Coma Scale (GCS) total score has well-known limitations, prompting calls for more sophisticated strategies.
Methods: We used item response theory (IRT) to develop a new method for quantifying TBI severity using 24 clinical, head computed tomography, and blood-based biomarker variables familiar to clinicians and researchers. IRT uses individuals' response patterns across indicators to estimate relationships between the indicators and a latent continuum of TBI severity. Model parameters were used to assign severity scores in two large cohorts, and associations with traditional GCS categories and 6-month functional outcomes (Glasgow Outcome Scale-Extended [GOSE]) were tested with correlational and logistic regression analyses.
Findings: In the prospective Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) cohort (N = 2545), modelling showed the 24 indicators index a common latent continuum of TBI severity. IRT enabled us to identify the relative contribution of these features to estimate an individual's TBI severity. Finally, within both the TRACK-TBI derivation sample and an external validation sample (Collaborative European NeuroTrauma Effectiveness Research in TBI [CENTER-TBI]), TBI severity scores generated using this novel IRT-based method incrementally predicted functional (GOSE) outcome better than classic clinical (mild, moderate, severe) or International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) classification methods.
Interpretation: Our findings directly inform ongoing international efforts to refine and deploy new pragmatic, empirically-supported strategies for characterising TBI, while illustrating a strategy that may be useful to improve staging systems for other diseases.
Funding: This secondary analysis project was funded by the U.S. National Institute of Neurological Disorders and Stroke (Grant No. R01 NS110856).
Keywords: Blood-based biomarkers; Classification; Item response theory; Neuroimaging; Severity; Traumatic brain injury.
Copyright © 2025 The Author(s). Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of interests Some of the blood-based biomarker measurements for the TRACK-TBI study were performed in kind by Abbott Laboratories. LDN: Received salary support for unrelated research from the U.S. Department of Defense, Centers for Disease Control and Prevention, and Medical College of Wisconsin Advancing a Healthier Wisconsin Endowment; personal compensation for independent consulting unrelated to this work for Resolys Bio, Inc.; and served as a chair for the Psychosocial and Environmental Modifiers Working Group for the 2024 NINDS TBI Classification and Nomenclature Initiative.). NT: Received salary support for unrelated research from the U.S. federal government. RDA: Received support for other research from the U.S. National Institutes of Health and Department of Defense; in-kind contributions from MesoScale Discoveries for immunoassay kits and reagents for unrelated research; and stock options and service on professional advisory boards for BrainBox Solutions, LLC and Nia Therapeutics. GTM: Received salary support for work on the TRACK-TBI study from the National Institute of Neurological Disorders and Stroke (NINDS); support for other research from the NINDS, Department of Defense/MTEC, Abbott Laboratories, National Football League; Funding from OneMind for patient engagement; and served on the Steering Committee for the 2024 NINDS TBI Classification and Nomenclature Initiative. AIRM: Received consulting fees from NeuroTrauma Sciences. LW: Received consulting fees from NeurotraumaSciences, Mass General Brigham and University of Wisconsin. DKM: Was supported by the CENTER-TBI grant (EU FP7 No 602150) and by funding for UK TBI-Repository and Data Portal Enabling Discovery (TBI-REPORTER) Grant (Ref: MR/Y008502/1), and is in receipt of research support, consultancy and/or lecture fees from NeuroTrauma Sciences, Lantamannen AB, GlaxoSmithKline Ltd, PressuraNeuro Ltd; Dompe; Invex Ltd; Abbot Ltd; and Integra Neurosciences Ltd).
Figures
Update of
-
Data-driven characterization of traumatic brain injury severity from clinical, neuroimaging, and blood-based indicators.Res Sq [Preprint]. 2024 Feb 16:rs.3.rs-3954157. doi: 10.21203/rs.3.rs-3954157/v1. Res Sq. 2024. Update in: EBioMedicine. 2025 Nov;121:106001. doi: 10.1016/j.ebiom.2025.106001. PMID: 38410436 Free PMC article. Updated. Preprint.
References
-
- Teasdale G., Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81–84. - PubMed
-
- Teasdale G., Maas A., Lecky F., Manley G., Stocchetti N., Murray G. The Glasgow coma scale at 40 years: standing the test of time. Lancet Neurol. 2014;13(8):844–854. - PubMed
-
- Rimel R.W., Giordani B., Barth J.T., Boll T.J., Jane J.A. Disability caused by minor head injury. Neurosurgery. 1981;9(3):221–228. - PubMed
-
- Rimel R.W., Giordani B., Barth J.T., Jane J.A. Moderate head injury: completing the clinical spectrum of brain trauma. Neurosurgery. 1982;11(3):344–351. - PubMed
-
- Gennarelli T.A., Spielman G.M., Langfitt T.W., et al. Influence of the type of intracranial lesion on outcome from severe head injury. J Neurosurg. 1982;56(1):26–32. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
